Evidence map›Paper›PMID 26730949›Full record

ArticlePloS one2016

p21CDKN1A Regulates the Binding of Poly(ADP-Ribose) Polymerase-1 to DNA Repair Intermediates.

Ilaria Dutto, Maria Sukhanova, Micol Tillhon, Ornella Cazzalini, Lucia A Stivala, A Ivana Scovassi, Olga Lavrik, Ennio Prosperi

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. CDKN1A/p21 in Breast Cancer: Part of the Problem, or Part of the Solution?International journal of molecular sciences · 2023
    Review
  2. Revisiting the Function of p21International journal of molecular sciences · 2022
    Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Ilaria DuttoIstituto di Genetica Molecolare del CNR, Via Abbiategrasso, 207, Pavia, Italy.
Maria SukhanovaInstitute of Chemical Biology and Fundamental Medicine, Russian Academy of Sciences, Prospekt Lavrentiev 8, Novosibirsk, Russian Federation.
Micol TillhonIstituto di Genetica Molecolare del CNR, Via Abbiategrasso, 207, Pavia, Italy.
Ornella CazzaliniDipartimento di Medicina Molecolare, Immunologia e Patologia, Università di Pavia, Via Ferrata 9, Pavia, Italy.
Lucia A StivalaDipartimento di Medicina Molecolare, Immunologia e Patologia, Università di Pavia, Via Ferrata 9, Pavia, Italy.
A Ivana ScovassiIstituto di Genetica Molecolare del CNR, Via Abbiategrasso, 207, Pavia, Italy.
Olga LavrikInstitute of Chemical Biology and Fundamental Medicine, Russian Academy of Sciences, Prospekt Lavrentiev 8, Novosibirsk, Russian Federation.
Ennio ProsperiIstituto di Genetica Molecolare del CNR, Via Abbiategrasso, 207, Pavia, Italy.
Istituto di Genetica Molecolare · ITUniversity of Pavia · ITInstitute of Chemical Biology and Fundamental Medicine · RURussian Academy of Sciences · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cell cycle inhibitor p21CDKN1A was previously found to interact directly with DNA nick-sensor poly(ADP-ribose) polymerase-1 (PARP-1) and to promote base excision repair (BER). However, the molecular mechanism responsible for this BER-related association of p21 with PARP-1 remains to be clarified. In this study we investigate the capability of p21 to influence PARP-1 binding to DNA repair intermediates in a reconstituted BER system in vitro. Using model photoreactive BER substrates containing single-strand breaks, we found that full-length recombinant GST-tagged p21 but not a C-terminal domain truncated form of p21 was able to stimulate the PARP-1 binding to BER intermediates with no significant influence on the catalytic activity of PARP-1. In addition, we investigate whether the activation of PARP-1 through poly(ADP-ribose) (PAR) synthesis, is required for its interaction with p21. We have found that in human fibroblasts and in HeLa cells treated with the DNA alkylating agent N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), the interaction of p21 with PARP-1 was greatly dependent on PAR synthesis. In fact, an anti-PAR antibody was able to co-immunoprecipitate p21 and PARP-1 from extracts of MNNG-treated cells, while blocking PAR synthesis with the PARP-1 inhibitor Olaparib, drastically reduced the amount of p21 co-immunoprecipitated by a PARP-1 antibody. Our results provide the first evidence that p21 can stimulate the binding of PARP-1 to DNA repair intermediates, and that this cooperation requires PAR synthesis.

Indexed as

DNA Breaks, Single-StrandedDNA RepairBlotting, WesternCell LineChromatinCyclin-Dependent Kinase Inhibitor p21FibroblastsHeLa CellsHumansMethylnitronitrosoguanidineMicroscopy, FluorescenceMutationPhthalazinesPiperazinesPoly Adenosine Diphosphate RibosePoly(ADP-ribose) Polymerase InhibitorsCDKN1A protein, humanChromatinCyclin-Dependent Kinase Inhibitor p21MethylnitronitrosoguanidineolaparibPhthalazinesPiperazinesPoly Adenosine Diphosphate RibosePoly(ADP-ribose) Polymerase InhibitorsPoly(ADP-ribose) Polymerases

Identifiers

PMID26730949
PMCPMC4701469
OpenAlexW2225096485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.